Skip to main content


FDA Approves First Generic ADVAIR DISKUS® for Asthma Treatment

The U.S. Food and Drug Administration today approved the first generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for the twice-daily treatment of asthma in patients aged four years and older and maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD).

Why the Weatherford, Texas, School Board’s Anaphylaxis Policy Is a Bad Idea

School is a common place for children to experience anaphylaxis – a serious allergic reaction. But the Weatherford Independent School District in Texas recently took a step backward. They created a policy that guides staff to give Benadryl® for severe allergic reactions, instead of unassigned stock epinephrine. But this goes against medical evidence.

GSK to Offer Generic Version of Ventolin HFA Albuterol Inhaler

The Asthma and Allergy Foundation of America is sharing this press release from GlaxoSmithKline to bring you the latest research news quickly. [PRESS RELEASE] GSK announces availability of Authorized Generic Albuterol Sulfate Inhaler for treatment or prevention of bronchospasm Effective, January 15, 2019, GSK announced the availability of an authorized generic (AG) of Ventolin HFA (albuterol sulfate) inhalation aerosol. The AG will be manufactured by GSK and distributed by Prasco LLC. The...

Hypoallergenic: Science or Marketing Hype?

It’s common to see the term “hypoallergenic” on many products and services. It’s a word many consumers have become comfortable with. It makes some believe anything with this label is better for them and less likely to trigger asthma and allergy symptoms. But you may be surprised to find there is no regulation on how a product can be labeled “hypoallergenic.”

Reducing the Chance of an Asthma Flare and Finding Support

Six years ago, Lisa Kelly went to see her doctor about a chronic cough. She learned she has severe uncontrolled asthma. With her doctor’s help, she has since tried various treatments to manage her asthma. They have each helped for a little while, but not as much as she would like. In 2017, she discovered the Asthma and Allergy Foundation of America's (AAFA) online community.

What Is a Biologic?

Biologics are targeted therapies made from living organisms or natural sources. Biologic therapy involves injections every few weeks or so that are tailored to the individual. Biologics help normalize your immune system by controlling immune responses that lead to inflammation. There are biologic treatments available for people with moderate-to-severe asthma or atopic dermatitis (eczema).

Teva Announces FDA Approval of ProAir® Digihaler™

Teva Pharmaceutical Industries Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved ProAir ® Digihaler™ (albuterol sulfate 117 mcg) inhalation powder, the first and only digital inhaler with built-in sensors which connects to a companion mobile application and provides inhaler use information to people with asthma and COPD. Learn more.

You Are an Important Part of Asthma and Allergy Research and Treatment

Earlier this year, AAFA surveyed members of our community about clinical trials for asthma and allergies. Most people said they would be willing to consider clinical trials. But only 9% of the people said they had been invited to participate in one! Learn what else we found about participation in clinical trials.

Atopic Dermatitis in America: Find Relief for This Painful Itchy Rash

If you have atopic dermatitis (AD) , you know a dry, itchy, red rash on your hands, arms, legs or other parts of the body is a part of daily life. AD is an allergic condition and the most common type of eczema. More than 18 million Americans of all ages have AD. The severity of AD can be different for each person and does not depend on when you developed the disease. However, AAFA’s recent study titled Atopic Dermatitis in America found that people with adult- and late childhood-onset AD...

Winter Weather Advisory – Cold Air and Asthma

Dry and/or cold air is a trigger for airway narrowing (bronchoconstriction) and can be a weather-related asthma trigger. When you breathe in cold, dry air through your mouth, the air doesn't get warmed by your nose first. The cold air goes to your lungs and airways. This can trigger an asthma attack. Try these tips to avoid having cold air trigger your asthma.

Global Initiative for Asthma (GINA) Recommends the Use of Fractional Exhaled Nitric Oxide (FeNO) Monitoring for Difficult-to-Treat and Severe Asthma Management

Circassia Pharmaceuticals, Inc. (“Circassia” or “the Company”), a specialty pharmaceutical company focused on respiratory disease, today announced that Fractional Exhaled Nitric Oxide (FeNO) monitoring is recommended in the latest Global Initiative for Asthma (GINA) guide, “Difficult-to-Treat & Severe Asthma in Adolescent and Adult Patients – Diagnosis and Management.”